<- Go home

Added to YB: 2022-02-04

Pitch date: 2022-02-04

VIVO [bullish]

Meridian Bioscience, Inc.

+40.6%

current return

Author Info

No bio for this author

Company Info

Meridian Bioscience, Inc. operates as a life science company that develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases and elevated blood lead levels.

Market Cap

$1.5B

Pitch Price

$24.16

Price Target

N/A

Dividend

N/A

EV/EBITDA

N/A

P/E

-549.37

EV/Sales

N/A

Sector

Health Care Equipment and Supplies

Category

N/A

Show full summary:
MERIDIAN BIOSCIENCE INC VIVO

A summary for this pitch has not been created yet.

Read full article (0 min)